Trial intelligence / Profile preview

Comparison of propofol and sevoflurane with and without remifentanil on anesthesia depth and hemodynamic stability

IRCT20210309050653N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of propofol, sevoflurane and remifentanil in None (4 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Mean bispectral index values, Mean arterial pressure change and 1 more. Started Nov 2021; status: completed.

02

Drugs

propofolsevofluraneremifentanil

Beyond the preview

Go deeper on IRCT20210309050653N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210309050653N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call